000			01805 a2200505 4500
005			20250513113527.0
264		0	_c19970409
008			199704s 0 0 eng d
022			_a0161-5505
040			_aNLM _beng _cNLM
100	1		_aBehr, T M
245	0	0	_aVariables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies. _h[electronic resource]
260			_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cMar 1997
300			_a409-18 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdenocarcinoma _xmetabolism
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xpharmacokinetics
650	0	4	_aCarcinoembryonic Antigen _xanalysis
650	0	4	_aColorectal Neoplasms _xmetabolism
650	0	4	_aFemale
650	0	4	_aHalf-Life
650	0	4	_aHumans
650	0	4	_aIodine Radioisotopes _xtherapeutic use
650	0	4	_aMale
650	0	4	_aManganese _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aMucins _xmetabolism
650	0	4	_aNeptunium _xtherapeutic use
650	0	4	_aOvarian Neoplasms _xmetabolism
650	0	4	_aRadioimmunotherapy
650	0	4	_aRadioisotopes _xtherapeutic use
650	0	4	_aRadiotherapy Dosage
650	0	4	_aThyroid Neoplasms _xmetabolism
650	0	4	_aTissue Distribution
650	0	4	_aTumor Cells, Cultured
700	1		_aSharkey, R M
700	1		_aJuweid, M E
700	1		_aDunn, R M
700	1		_aYing, Z
700	1		_aZhang, C H
700	1		_aSiegel, J A
700	1		_aGoldenberg, D M
773	0		_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 38 _gno. 3 _gp. 409-18
999			_c9061199 _d9061199